Il y a eu 50 transactions d'initiés récentes enregistrées pour Clearside Biomedical, Inc. (CLSD), dont 38 achats et 9 ventes. Le total des achats d'initiés s'élève à $4.55M et le total des ventes d'initiés à $136.04K.
Les initiés notables ayant une activité récente comprennent Thorp Clay, Lasezkay George M, Deignan Charles A.. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — CLSD
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2025-02-24 |
Thorp Clay |
Director |
Achat Informatif |
15,000 |
$0.92 |
$13.8K |
176,141 |
| 2025-01-08 |
Lasezkay George M |
CEO |
Attribution de RSU |
500,000 |
$0.97 |
$485K |
500,000 |
| 2025-01-08 |
Deignan Charles A. |
Chief Financial Officer |
Attribution de RSU |
200,000 |
$0.97 |
$194K |
200,000 |
| 2025-01-08 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Attribution de RSU |
250,000 |
$0.97 |
$242.5K |
250,000 |
| 2024-11-01 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Achat Informatif |
36,500 |
$1.00 |
$36.5K |
100,000 |
| 2024-06-24 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Achat Informatif |
23,500 |
$1.06 |
$24.91K |
63,500 |
| 2024-06-20 |
Yerxa Benjamin R |
Director |
Attribution de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Shaffer Christy L |
Director |
Attribution de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Edwards Jeffrey L |
Director |
Attribution de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Hutson Nancy J |
Director |
Attribution de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Thorp Clay |
Director |
Attribution de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Croarkin Richard |
Director |
Attribution de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Humphries William D. |
Director |
Attribution de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-06-20 |
Gibney Anthony S |
Director |
Attribution de RSU |
45,000 |
$1.15 |
$51.75K |
45,000 |
| 2024-05-15 |
Yerxa Benjamin R |
Director |
Achat Informatif |
7,813 |
$1.31 |
$10.24K |
17,957 |
| 2024-04-18 |
Gibney Anthony S |
Director |
Achat Informatif |
93,290 |
$1.30 |
$121.28K |
100,000 |
| 2024-04-17 |
Gibney Anthony S |
Director |
Achat Informatif |
6,710 |
$1.25 |
$8.39K |
6,710 |
| 2024-04-15 |
Gibney Anthony S |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-04-15 |
Gibney Anthony S |
Director |
Attribution de RSU |
45,000 |
$1.29 |
$58.05K |
45,000 |
| 2024-03-20 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Achat Informatif |
30,000 |
$1.60 |
$48K |
30,000 |
| 2024-03-18 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Attribution de RSU |
450,000 |
$1.56 |
$702K |
450,000 |
| 2024-03-14 |
Chong Ngai Hang Victor |
Officer |
Inconnu |
- |
- |
- |
- |
| 2024-03-14 |
Chong Ngai Hang Victor |
Chief Medical Officer |
Cession |
- |
- |
- |
10,000 |
| 2024-02-07 |
Whitmore Bradford T |
10 Percent Owner |
Achat Informatif |
444,444 |
$1.62 |
$720K |
444,444 |
| 2024-01-19 |
Lasezkay George M |
CEO |
Vente Informative |
18,000 |
$1.27 |
$22.86K |
466,577 |
| 2024-01-19 |
Deignan Charles A. |
Chief Financial Officer |
Vente Informative |
12,900 |
$1.28 |
$16.51K |
384,662 |
| 2024-01-18 |
Lasezkay George M |
CEO |
Attribution de RSU |
439,500 |
$1.29 |
$566.96K |
439,500 |
| 2024-01-18 |
Deignan Charles A. |
Chief Financial Officer |
Attribution de RSU |
200,000 |
$1.29 |
$258K |
200,000 |
| 2023-11-01 |
Whitmore Bradford T |
10 Percent Owner |
Achat Informatif |
64,366 |
$0.74 |
$47.9K |
4,050,590 |
| 2023-10-31 |
Whitmore Bradford T |
10 Percent Owner |
Achat Informatif |
70,812 |
$0.73 |
$51.54K |
3,986,224 |
| 2023-10-30 |
Whitmore Bradford T |
10 Percent Owner |
Achat Informatif |
600 |
$0.69 |
$411.00 |
3,915,412 |
| 2023-10-27 |
Whitmore Bradford T |
10 Percent Owner |
Inconnu |
- |
- |
- |
2,350,152 |
| 2023-10-03 |
Hutson Nancy J |
Director |
Achat Informatif |
10,000 |
$0.86 |
$8.6K |
93,000 |
| 2023-09-25 |
Thorp Clay |
Director |
Achat Informatif |
10,000 |
$0.86 |
$8.6K |
40,522 |
| 2023-09-22 |
Humphries William D. |
Director |
Exercice d'Options (Vente) |
22,727 |
$0.40 |
$9.09K |
- |
| 2023-09-18 |
Lasezkay George M |
CEO |
Attribution de RSU |
200,000 |
$0.85 |
$169.8K |
200,000 |
| 2023-09-18 |
Deignan Charles A. |
Chief Financial Officer |
Attribution de RSU |
100,000 |
$0.85 |
$84.9K |
100,000 |
| 2023-09-13 |
Deignan Charles A. |
Chief Financial Officer |
Exercice d'Options (Vente) |
34,090 |
$0.40 |
$13.64K |
- |
| 2023-06-22 |
Yerxa Benjamin R |
Director |
Attribution de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Shaffer Christy L |
Director |
Attribution de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Edwards Jeffrey L |
Director |
Attribution de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Hutson Nancy J |
Director |
Attribution de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Thorp Clay |
Director |
Attribution de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Croarkin Richard |
Director |
Attribution de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-06-22 |
Humphries William D. |
Director |
Attribution de RSU |
30,000 |
$1.31 |
$39.3K |
30,000 |
| 2023-01-20 |
Ciulla Thomas |
Chief Medical Officer |
Vente Informative |
13,700 |
$1.47 |
$20.14K |
291,890 |
| 2023-01-19 |
Lasezkay George M |
CEO |
Vente Informative |
20,030 |
$1.46 |
$29.24K |
484,577 |
| 2023-01-19 |
Deignan Charles A. |
Chief Financial Officer |
Vente Informative |
14,030 |
$1.50 |
$21.05K |
363,472 |
| 2023-01-10 |
Ciulla Thomas |
Chief Medical Officer |
Vente Informative |
2,170 |
$1.62 |
$3.52K |
305,590 |
| 2023-01-04 |
Lasezkay George M |
CEO |
Attribution de RSU |
487,500 |
- |
- |
487,500 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
